Pharma & Healthcare

Global Azelastine Drug Market Insights, Forecast to 2030

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.
The global Azelastine Drug market is projected to grow from US$ 658 million in 2024 to US$ 987.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Azelastine Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Azelastine Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Azelastine Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Azelastine Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Azelastine Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Azelastine Drug sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Yunfeng Pharma
Sun Pharma
Amneal Pharmaceuticals
Zhongsheng Pharma
Hikma Pharmaceuticals
Perrigo
Alkem Labs
Jiangxi Zhenshiming Pharmaceutical
Segment by Type
Nasal Spray
Eye Drops
Other
Segment by Application
Hospital
Retail Pharmacy
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Azelastine Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Azelastine Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Azelastine Drug sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Azelastine Drug Product Introduction
1.2 Market by Type
1.2.1 Global Azelastine Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Nasal Spray
1.2.3 Eye Drops
1.2.4 Other
1.3 Market by Application
1.3.1 Global Azelastine Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Azelastine Drug Sales Estimates and Forecasts 2019-2030
2.2 Global Azelastine Drug Revenue by Region
2.2.1 Global Azelastine Drug Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Azelastine Drug Revenue by Region (2019-2024)
2.2.3 Global Azelastine Drug Revenue by Region (2025-2030)
2.2.4 Global Azelastine Drug Revenue Market Share by Region (2019-2030)
2.3 Global Azelastine Drug Sales Estimates and Forecasts 2019-2030
2.4 Global Azelastine Drug Sales by Region
2.4.1 Global Azelastine Drug Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Azelastine Drug Sales by Region (2019-2024)
2.4.3 Global Azelastine Drug Sales by Region (2025-2030)
2.4.4 Global Azelastine Drug Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Azelastine Drug Sales by Manufacturers
3.1.1 Global Azelastine Drug Sales by Manufacturers (2019-2024)
3.1.2 Global Azelastine Drug Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Azelastine Drug in 2023
3.2 Global Azelastine Drug Revenue by Manufacturers
3.2.1 Global Azelastine Drug Revenue by Manufacturers (2019-2024)
3.2.2 Global Azelastine Drug Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Azelastine Drug Revenue in 2023
3.3 Global Key Players of Azelastine Drug, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Azelastine Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Azelastine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Azelastine Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Azelastine Drug, Product Offered and Application
3.8 Global Key Manufacturers of Azelastine Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Azelastine Drug Sales by Type
4.1.1 Global Azelastine Drug Historical Sales by Type (2019-2024)
4.1.2 Global Azelastine Drug Forecasted Sales by Type (2025-2030)
4.1.3 Global Azelastine Drug Sales Market Share by Type (2019-2030)
4.2 Global Azelastine Drug Revenue by Type
4.2.1 Global Azelastine Drug Historical Revenue by Type (2019-2024)
4.2.2 Global Azelastine Drug Forecasted Revenue by Type (2025-2030)
4.2.3 Global Azelastine Drug Revenue Market Share by Type (2019-2030)
4.3 Global Azelastine Drug Price by Type
4.3.1 Global Azelastine Drug Price by Type (2019-2024)
4.3.2 Global Azelastine Drug Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Azelastine Drug Sales by Application
5.1.1 Global Azelastine Drug Historical Sales by Application (2019-2024)
5.1.2 Global Azelastine Drug Forecasted Sales by Application (2025-2030)
5.1.3 Global Azelastine Drug Sales Market Share by Application (2019-2030)
5.2 Global Azelastine Drug Revenue by Application
5.2.1 Global Azelastine Drug Historical Revenue by Application (2019-2024)
5.2.2 Global Azelastine Drug Forecasted Revenue by Application (2025-2030)
5.2.3 Global Azelastine Drug Revenue Market Share by Application (2019-2030)
5.3 Global Azelastine Drug Price by Application
5.3.1 Global Azelastine Drug Price by Application (2019-2024)
5.3.2 Global Azelastine Drug Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Azelastine Drug Market Size by Type
6.1.1 US & Canada Azelastine Drug Sales by Type (2019-2030)
6.1.2 US & Canada Azelastine Drug Revenue by Type (2019-2030)
6.2 US & Canada Azelastine Drug Market Size by Application
6.2.1 US & Canada Azelastine Drug Sales by Application (2019-2030)
6.2.2 US & Canada Azelastine Drug Revenue by Application (2019-2030)
6.3 US & Canada Azelastine Drug Market Size by Country
6.3.1 US & Canada Azelastine Drug Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Azelastine Drug Sales by Country (2019-2030)
6.3.3 US & Canada Azelastine Drug Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Azelastine Drug Market Size by Type
7.1.1 Europe Azelastine Drug Sales by Type (2019-2030)
7.1.2 Europe Azelastine Drug Revenue by Type (2019-2030)
7.2 Europe Azelastine Drug Market Size by Application
7.2.1 Europe Azelastine Drug Sales by Application (2019-2030)
7.2.2 Europe Azelastine Drug Revenue by Application (2019-2030)
7.3 Europe Azelastine Drug Market Size by Country
7.3.1 Europe Azelastine Drug Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Azelastine Drug Sales by Country (2019-2030)
7.3.3 Europe Azelastine Drug Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Azelastine Drug Market Size
8.1.1 China Azelastine Drug Sales (2019-2030)
8.1.2 China Azelastine Drug Revenue (2019-2030)
8.2 China Azelastine Drug Market Size by Application
8.2.1 China Azelastine Drug Sales by Application (2019-2030)
8.2.2 China Azelastine Drug Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Azelastine Drug Market Size by Type
9.1.1 Asia Azelastine Drug Sales by Type (2019-2030)
9.1.2 Asia Azelastine Drug Revenue by Type (2019-2030)
9.2 Asia Azelastine Drug Market Size by Application
9.2.1 Asia Azelastine Drug Sales by Application (2019-2030)
9.2.2 Asia Azelastine Drug Revenue by Application (2019-2030)
9.3 Asia Azelastine Drug Sales by Region
9.3.1 Asia Azelastine Drug Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Azelastine Drug Revenue by Region (2019-2030)
9.3.3 Asia Azelastine Drug Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Azelastine Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Azelastine Drug Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Azelastine Drug Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Azelastine Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Azelastine Drug Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Azelastine Drug Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Azelastine Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Azelastine Drug Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Azelastine Drug Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Azelastine Drug Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Viatris
11.1.1 Viatris Company Information
11.1.2 Viatris Overview
11.1.3 Viatris Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Viatris Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Viatris Recent Developments
11.2 Apotex
11.2.1 Apotex Company Information
11.2.2 Apotex Overview
11.2.3 Apotex Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Apotex Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Apotex Recent Developments
11.3 Yunfeng Pharma
11.3.1 Yunfeng Pharma Company Information
11.3.2 Yunfeng Pharma Overview
11.3.3 Yunfeng Pharma Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Yunfeng Pharma Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Yunfeng Pharma Recent Developments
11.4 Sun Pharma
11.4.1 Sun Pharma Company Information
11.4.2 Sun Pharma Overview
11.4.3 Sun Pharma Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sun Pharma Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharma Recent Developments
11.5 Amneal Pharmaceuticals
11.5.1 Amneal Pharmaceuticals Company Information
11.5.2 Amneal Pharmaceuticals Overview
11.5.3 Amneal Pharmaceuticals Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Amneal Pharmaceuticals Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Amneal Pharmaceuticals Recent Developments
11.6 Zhongsheng Pharma
11.6.1 Zhongsheng Pharma Company Information
11.6.2 Zhongsheng Pharma Overview
11.6.3 Zhongsheng Pharma Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Zhongsheng Pharma Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Zhongsheng Pharma Recent Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Company Information
11.7.2 Hikma Pharmaceuticals Overview
11.7.3 Hikma Pharmaceuticals Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hikma Pharmaceuticals Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hikma Pharmaceuticals Recent Developments
11.8 Perrigo
11.8.1 Perrigo Company Information
11.8.2 Perrigo Overview
11.8.3 Perrigo Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Perrigo Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Perrigo Recent Developments
11.9 Alkem Labs
11.9.1 Alkem Labs Company Information
11.9.2 Alkem Labs Overview
11.9.3 Alkem Labs Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Alkem Labs Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Alkem Labs Recent Developments
11.10 Jiangxi Zhenshiming Pharmaceutical
11.10.1 Jiangxi Zhenshiming Pharmaceutical Company Information
11.10.2 Jiangxi Zhenshiming Pharmaceutical Overview
11.10.3 Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangxi Zhenshiming Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Azelastine Drug Industry Chain Analysis
12.2 Azelastine Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Azelastine Drug Production Mode & Process
12.4 Azelastine Drug Sales and Marketing
12.4.1 Azelastine Drug Sales Channels
12.4.2 Azelastine Drug Distributors
12.5 Azelastine Drug Customers
13 Market Dynamics
13.1 Azelastine Drug Industry Trends
13.2 Azelastine Drug Market Drivers
13.3 Azelastine Drug Market Challenges
13.4 Azelastine Drug Market Restraints
14 Key Findings in The Global Azelastine Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Azelastine Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Nasal Spray
Table 3. Major Manufacturers of Eye Drops
Table 4. Major Manufacturers of Other
Table 5. Global Azelastine Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Azelastine Drug Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Azelastine Drug Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Azelastine Drug Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Azelastine Drug Revenue Market Share by Region (2019-2024)
Table 10. Global Azelastine Drug Revenue Market Share by Region (2025-2030)
Table 11. Global Azelastine Drug Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Azelastine Drug Sales by Region (2019-2024) & (K Units)
Table 13. Global Azelastine Drug Sales by Region (2025-2030) & (K Units)
Table 14. Global Azelastine Drug Sales Market Share by Region (2019-2024)
Table 15. Global Azelastine Drug Sales Market Share by Region (2025-2030)
Table 16. Global Azelastine Drug Sales by Manufacturers (2019-2024) & (K Units)
Table 17. Global Azelastine Drug Sales Share by Manufacturers (2019-2024)
Table 18. Global Azelastine Drug Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Azelastine Drug Revenue Share by Manufacturers (2019-2024)
Table 20. Global Key Players of Azelastine Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 21. Azelastine Drug Price by Manufacturers 2019-2024 (US$/Unit)
Table 22. Global Azelastine Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Azelastine Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Azelastine Drug as of 2023)
Table 24. Global Key Manufacturers of Azelastine Drug, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Azelastine Drug, Product Offered and Application
Table 26. Global Key Manufacturers of Azelastine Drug, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Azelastine Drug Sales by Type (2019-2024) & (K Units)
Table 29. Global Azelastine Drug Sales by Type (2025-2030) & (K Units)
Table 30. Global Azelastine Drug Sales Share by Type (2019-2024)
Table 31. Global Azelastine Drug Sales Share by Type (2025-2030)
Table 32. Global Azelastine Drug Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Azelastine Drug Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Azelastine Drug Revenue Share by Type (2019-2024)
Table 35. Global Azelastine Drug Revenue Share by Type (2025-2030)
Table 36. Azelastine Drug Price by Type (2019-2024) & (US$/Unit)
Table 37. Global Azelastine Drug Price Forecast by Type (2025-2030) & (US$/Unit)
Table 38. Global Azelastine Drug Sales by Application (2019-2024) & (K Units)
Table 39. Global Azelastine Drug Sales by Application (2025-2030) & (K Units)
Table 40. Global Azelastine Drug Sales Share by Application (2019-2024)
Table 41. Global Azelastine Drug Sales Share by Application (2025-2030)
Table 42. Global Azelastine Drug Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Azelastine Drug Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Azelastine Drug Revenue Share by Application (2019-2024)
Table 45. Global Azelastine Drug Revenue Share by Application (2025-2030)
Table 46. Azelastine Drug Price by Application (2019-2024) & (US$/Unit)
Table 47. Global Azelastine Drug Price Forecast by Application (2025-2030) & (US$/Unit)
Table 48. US & Canada Azelastine Drug Sales by Type (2019-2024) & (K Units)
Table 49. US & Canada Azelastine Drug Sales by Type (2025-2030) & (K Units)
Table 50. US & Canada Azelastine Drug Revenue by Type (2019-2024) & (US$ Million)
Table 51. US & Canada Azelastine Drug Revenue by Type (2025-2030) & (US$ Million)
Table 52. US & Canada Azelastine Drug Sales by Application (2019-2024) & (K Units)
Table 53. US & Canada Azelastine Drug Sales by Application (2025-2030) & (K Units)
Table 54. US & Canada Azelastine Drug Revenue by Application (2019-2024) & (US$ Million)
Table 55. US & Canada Azelastine Drug Revenue by Application (2025-2030) & (US$ Million)
Table 56. US & Canada Azelastine Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 57. US & Canada Azelastine Drug Revenue by Country (2019-2024) & (US$ Million)
Table 58. US & Canada Azelastine Drug Revenue by Country (2025-2030) & (US$ Million)
Table 59. US & Canada Azelastine Drug Sales by Country (2019-2024) & (K Units)
Table 60. US & Canada Azelastine Drug Sales by Country (2025-2030) & (K Units)
Table 61. Europe Azelastine Drug Sales by Type (2019-2024) & (K Units)
Table 62. Europe Azelastine Drug Sales by Type (2025-2030) & (K Units)
Table 63. Europe Azelastine Drug Revenue by Type (2019-2024) & (US$ Million)
Table 64. Europe Azelastine Drug Revenue by Type (2025-2030) & (US$ Million)
Table 65. Europe Azelastine Drug Sales by Application (2019-2024) & (K Units)
Table 66. Europe Azelastine Drug Sales by Application (2025-2030) & (K Units)
Table 67. Europe Azelastine Drug Revenue by Application (2019-2024) & (US$ Million)
Table 68. Europe Azelastine Drug Revenue by Application (2025-2030) & (US$ Million)
Table 69. Europe Azelastine Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 70. Europe Azelastine Drug Revenue by Country (2019-2024) & (US$ Million)
Table 71. Europe Azelastine Drug Revenue by Country (2025-2030) & (US$ Million)
Table 72. Europe Azelastine Drug Sales by Country (2019-2024) & (K Units)
Table 73. Europe Azelastine Drug Sales by Country (2025-2030) & (K Units)
Table 74. China Azelastine Drug Sales by Type (2019-2024) & (K Units)
Table 75. China Azelastine Drug Sales by Type (2025-2030) & (K Units)
Table 76. China Azelastine Drug Revenue by Type (2019-2024) & (US$ Million)
Table 77. China Azelastine Drug Revenue by Type (2025-2030) & (US$ Million)
Table 78. China Azelastine Drug Sales by Application (2019-2024) & (K Units)
Table 79. China Azelastine Drug Sales by Application (2025-2030) & (K Units)
Table 80. China Azelastine Drug Revenue by Application (2019-2024) & (US$ Million)
Table 81. China Azelastine Drug Revenue by Application (2025-2030) & (US$ Million)
Table 82. Asia Azelastine Drug Sales by Type (2019-2024) & (K Units)
Table 83. Asia Azelastine Drug Sales by Type (2025-2030) & (K Units)
Table 84. Asia Azelastine Drug Revenue by Type (2019-2024) & (US$ Million)
Table 85. Asia Azelastine Drug Revenue by Type (2025-2030) & (US$ Million)
Table 86. Asia Azelastine Drug Sales by Application (2019-2024) & (K Units)
Table 87. Asia Azelastine Drug Sales by Application (2025-2030) & (K Units)
Table 88. Asia Azelastine Drug Revenue by Application (2019-2024) & (US$ Million)
Table 89. Asia Azelastine Drug Revenue by Application (2025-2030) & (US$ Million)
Table 90. Asia Azelastine Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Asia Azelastine Drug Revenue by Region (2019-2024) & (US$ Million)
Table 92. Asia Azelastine Drug Revenue by Region (2025-2030) & (US$ Million)
Table 93. Asia Azelastine Drug Sales by Region (2019-2024) & (K Units)
Table 94. Asia Azelastine Drug Sales by Region (2025-2030) & (K Units)
Table 95. Middle East, Africa and Latin America Azelastine Drug Sales by Type (2019-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Azelastine Drug Sales by Type (2025-2030) & (K Units)
Table 97. Middle East, Africa and Latin America Azelastine Drug Revenue by Type (2019-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Azelastine Drug Revenue by Type (2025-2030) & (US$ Million)
Table 99. Middle East, Africa and Latin America Azelastine Drug Sales by Application (2019-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Azelastine Drug Sales by Application (2025-2030) & (K Units)
Table 101. Middle East, Africa and Latin America Azelastine Drug Revenue by Application (2019-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Azelastine Drug Revenue by Application (2025-2030) & (US$ Million)
Table 103. Middle East, Africa and Latin America Azelastine Drug Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 104. Middle East, Africa and Latin America Azelastine Drug Revenue by Country (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Azelastine Drug Revenue by Country (2025-2030) & (US$ Million)
Table 106. Middle East, Africa and Latin America Azelastine Drug Sales by Country (2019-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Azelastine Drug Sales by Country (2025-2030) & (K Units)
Table 108. Viatris Company Information
Table 109. Viatris Description and Major Businesses
Table 110. Viatris Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 111. Viatris Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Viatris Recent Developments
Table 113. Apotex Company Information
Table 114. Apotex Description and Major Businesses
Table 115. Apotex Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 116. Apotex Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Apotex Recent Developments
Table 118. Yunfeng Pharma Company Information
Table 119. Yunfeng Pharma Description and Major Businesses
Table 120. Yunfeng Pharma Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 121. Yunfeng Pharma Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Yunfeng Pharma Recent Developments
Table 123. Sun Pharma Company Information
Table 124. Sun Pharma Description and Major Businesses
Table 125. Sun Pharma Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 126. Sun Pharma Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sun Pharma Recent Developments
Table 128. Amneal Pharmaceuticals Company Information
Table 129. Amneal Pharmaceuticals Description and Major Businesses
Table 130. Amneal Pharmaceuticals Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 131. Amneal Pharmaceuticals Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Amneal Pharmaceuticals Recent Developments
Table 133. Zhongsheng Pharma Company Information
Table 134. Zhongsheng Pharma Description and Major Businesses
Table 135. Zhongsheng Pharma Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 136. Zhongsheng Pharma Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Zhongsheng Pharma Recent Developments
Table 138. Hikma Pharmaceuticals Company Information
Table 139. Hikma Pharmaceuticals Description and Major Businesses
Table 140. Hikma Pharmaceuticals Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 141. Hikma Pharmaceuticals Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Hikma Pharmaceuticals Recent Developments
Table 143. Perrigo Company Information
Table 144. Perrigo Description and Major Businesses
Table 145. Perrigo Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 146. Perrigo Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Perrigo Recent Developments
Table 148. Alkem Labs Company Information
Table 149. Alkem Labs Description and Major Businesses
Table 150. Alkem Labs Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 151. Alkem Labs Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Alkem Labs Recent Developments
Table 153. Jiangxi Zhenshiming Pharmaceutical Company Information
Table 154. Jiangxi Zhenshiming Pharmaceutical Description and Major Businesses
Table 155. Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 156. Jiangxi Zhenshiming Pharmaceutical Azelastine Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Jiangxi Zhenshiming Pharmaceutical Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Azelastine Drug Distributors List
Table 161. Azelastine Drug Customers List
Table 162. Azelastine Drug Market Trends
Table 163. Azelastine Drug Market Drivers
Table 164. Azelastine Drug Market Challenges
Table 165. Azelastine Drug Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Azelastine Drug Product Picture
Figure 2. Global Azelastine Drug Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Azelastine Drug Market Share by Type in 2023 & 2030
Figure 4. Nasal Spray Product Picture
Figure 5. Eye Drops Product Picture
Figure 6. Other Product Picture
Figure 7. Global Azelastine Drug Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Azelastine Drug Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Other
Figure 12. Azelastine Drug Report Years Considered
Figure 13. Global Azelastine Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Azelastine Drug Revenue 2019-2030 (US$ Million)
Figure 15. Global Azelastine Drug Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Azelastine Drug Revenue Market Share by Region (2019-2030)
Figure 17. Global Azelastine Drug Sales 2019-2030 ((K Units)
Figure 18. Global Azelastine Drug Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Azelastine Drug Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Azelastine Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Azelastine Drug Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Azelastine Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Azelastine Drug Sales YoY (2019-2030) & (K Units)
Figure 24. China Azelastine Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Azelastine Drug Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Azelastine Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Azelastine Drug Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Azelastine Drug Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Azelastine Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Azelastine Drug in the World: Market Share by Azelastine Drug Revenue in 2023
Figure 31. Global Azelastine Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Azelastine Drug Sales Market Share by Type (2019-2030)
Figure 33. Global Azelastine Drug Revenue Market Share by Type (2019-2030)
Figure 34. Global Azelastine Drug Sales Market Share by Application (2019-2030)
Figure 35. Global Azelastine Drug Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Azelastine Drug Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Azelastine Drug Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Azelastine Drug Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Azelastine Drug Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Azelastine Drug Revenue Share by Country (2019-2030)
Figure 41. US & Canada Azelastine Drug Sales Share by Country (2019-2030)
Figure 42. U.S. Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Azelastine Drug Sales Market Share by Type (2019-2030)
Figure 45. Europe Azelastine Drug Revenue Market Share by Type (2019-2030)
Figure 46. Europe Azelastine Drug Sales Market Share by Application (2019-2030)
Figure 47. Europe Azelastine Drug Revenue Market Share by Application (2019-2030)
Figure 48. Europe Azelastine Drug Revenue Share by Country (2019-2030)
Figure 49. Europe Azelastine Drug Sales Share by Country (2019-2030)
Figure 50. Germany Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 51. France Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 55. China Azelastine Drug Sales Market Share by Type (2019-2030)
Figure 56. China Azelastine Drug Revenue Market Share by Type (2019-2030)
Figure 57. China Azelastine Drug Sales Market Share by Application (2019-2030)
Figure 58. China Azelastine Drug Revenue Market Share by Application (2019-2030)
Figure 59. Asia Azelastine Drug Sales Market Share by Type (2019-2030)
Figure 60. Asia Azelastine Drug Revenue Market Share by Type (2019-2030)
Figure 61. Asia Azelastine Drug Sales Market Share by Application (2019-2030)
Figure 62. Asia Azelastine Drug Revenue Market Share by Application (2019-2030)
Figure 63. Asia Azelastine Drug Revenue Share by Region (2019-2030)
Figure 64. Asia Azelastine Drug Sales Share by Region (2019-2030)
Figure 65. Japan Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 69. India Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Azelastine Drug Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Azelastine Drug Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Azelastine Drug Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Azelastine Drug Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Azelastine Drug Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Azelastine Drug Sales Share by Country (2019-2030)
Figure 76. Brazil Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Azelastine Drug Revenue (2019-2030) & (US$ Million)
Figure 81. Azelastine Drug Value Chain
Figure 82. Azelastine Drug Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies